Ashland Inc. ASH

Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.

Con 14 acciones de ASH (USD 966,00) habrías recibido USD 23,52 en dividendos en los últimos 12 meses.

ASH separó parte de su negocio en una nueva empresa (spin-off) el 15 de mayo de 2017. Sus accionistas recibieron acciones de la nueva compañía, y por eso el precio histórico de ASH está ajustado.

• Zacks Investment Research 29 sept

  ASH's Shares Rally 30% in 6 Months: What's Driving the Upside?

  Ashland Inc. (ASH) shares have surged 30.2% over the past six months, significantly outperforming its industry. The rally is driven by improved margin resilience from cost reductions and portfolio optimization, strong free cash flow generation of $103 million, and a doubled $1 billion share buyback authorization. The company's shift to a business-unit-focused operating model supports profitable growth in specialty chemicals.

  

• Zacks Investment Research 16 sept

  Here's Why You Should Retain ASH Stock in Your Portfolio Now

  Ashland Inc. is improving its specialty chemicals portfolio through cost reductions and operational efficiency, generating $103 million in Q3 free cash flow and approving a $1 billion share repurchase program. However, the company faces headwinds from weak industrial demand, logistics pressures, tariffs (approximately $70 million impact expected), and concentration risk in consumer-oriented businesses. ASH stock has gained 37.5% over the past year but carries a Zacks Rank #3 (Hold) rating.

  

• GlobeNewswire Inc. 31 ago

  Ashland to host Innovation Day for analysts and investors

  Ashland Inc. will host an Innovation Day webcast on September 17, 2026, to present updates on its Technology Platforms, commercial progress, and scalability. The event will feature presentations from company executives and senior technology leaders discussing innovations and commercial opportunities across key markets. A live Q&A session will follow the formal remarks, with the webcast available for replay.

  

• GlobeNewswire Inc. 28 jul

  Global Pharmaceutical Surfactants Market Size/Share Worth USD 6.93 Billion by 2035 at a 4.42% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

  The global pharmaceutical surfactants market was valued at USD 4.5 billion in 2025 and is projected to reach USD 6.93 billion by 2035, growing at a CAGR of 4.42%. The market is driven by increasing demand for improved drug formulation, delivery systems, and expanding healthcare infrastructure. Non-ionic surfactants currently hold the largest market share, while Asia-Pacific is expected to be the fastest-growing region.

  

• GlobeNewswire Inc. 10 jun

  Ashland responds to investor presentation by Ancora Alternatives LLC

  Ashland Inc. issued a statement responding to an investor presentation by Ancora Alternatives LLC, reaffirming its commitment to shareholder value creation and its growth strategies. The company stated it intends to engage constructively with Ancora despite the activist investor not engaging prior to its presentation. Ashland's Board continues to evaluate strategy and capital allocation regularly.